RecruitingNCT05755867

Global PNH Patient Registry

Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Patient Registry


Sponsor

Aplastic Anemia and MDS International Foundation

Enrollment

500 participants

Start Date

May 6, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

The primary aim of the Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Patient Registry is to conduct a prospectively-planned and efficient natural history study that will result in a more comprehensive understanding of the disease and its course and pace over time. Other registry objectives include the following: * Provide a convenient online platform for participants (or caregivers) to self-report cases of PNH. * Develop a communications registry within the Global PNH Patient registry (e.g., to notify patients of research studies and clinical trials). * Characterize and describe the Global PNH population as a whole, enhancing the understanding of disease prevalence and phenotype as well as the rate of progression of disease characteristics. * Assist the PNH community with the development of recommendations and standards of care. * Be a case-finding resource to be used for researchers who seek to study the pathophysiology of PNH, retrospectively collate intervention outcomes, and design prospective trials of novel treatments.


Eligibility

Inclusion Criteria5

  • \- Individuals of any age with a confirmed diagnosis of PNH or diagnosis consistent with PNH are eligible for inclusion. PNH is defined as a genetic mutation in the PIG-A gene.
  • Individuals must be willing to provide informed consent. Participants can be:
  • legal adult participants who are able to provide their own consent;
  • children and adults unable to provide their own consent, for whom consent must be provided by a Legally Authorized Representative (LAR) who is a legal adult.
  • Individuals must have at least periodic access to the internet and be able to comply with web-based study procedures and data collections

Exclusion Criteria1

  • Individuals not able to read and understand English.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Aplastic Anemia and MDS International Foundation

Bethesda, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05755867


Related Trials